Learn more

GLYCOFI INC

Overview
  • Total Patents
    235
  • GoodIP Patent Rank
    144,692
  • Filing trend
    ⇩ 100.0%
About

GLYCOFI INC has a total of 235 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are GREENOVATION BIOTECH GMBH, GERNGROSS TILLMAN U and WUHU YINGTE FEIER BIOLOGICAL PRODUCT INDUSTRY RES INSTITUTE CO LTD.

Patent filings per year

Chart showing GLYCOFI INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wildt Stefan 91
#2 Gerngross Tillman U 78
#3 Bobrowicz Piotr 56
#4 Hamilton Stephen R 50
#5 Choi Byung-Kwon 50
#6 Davidson Robert C 40
#7 Li Huijuan 34
#8 Nett Juergen Hermann 31
#9 Nett Juergen 30
#10 Davidson Robert 21

Latest patents

Publication Filing date Title
AU2012227297A1 Combinatorial DNA Library for Producing Modified N-Glycans in Lower Eukaryotes
AU2012203729A1 Production of glycoproteins with reduced O-glycosylation
JP2012100664A Method for reducing or eliminating alpha-mannosidase-resistant glycan in production of glycoprotein
AU2011205185A1 Production of galactosylated glycoproteins in lower eukaryotes
AU2009282228A1 Improved vectors and yeast strains for protein production: Ca2+ ATPase overexpression
WO2009146362A1 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose
WO2009111183A1 Surface display of recombinant proteins in lower eukaryotes
CA2714166A1 Vectors and yeast strains for protein production
WO2009085135A2 Yeast strains for protein production
CN101679934A Production of glycoproteins with modified fucosylation
CN101535340A Erythropoietin compositions
KR20090016596A Erythropoietin compositions
CN101365783A Production of glycoproteins with reduced o-glycosylation
EP1942935A2 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform
CN101252950A Immunoglobulins comprising predominantly a GLCNACMAN3GLCNAC2 sugar form
US2006286637A1 Production of sialylated N-glycans in lower eukaryotes
US2006252096A1 Single chain antibody with cleavable linker
WO2006071856A2 Immunoglobulins comprising predominantly a man5glcnac2 glycoform
US2006257399A1 Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
CA2620713A1 Immunoglobulin comprising predominantly a man7glcnac2, man8glcnac2 glycoform